Tienta Products

Tienta’s strategic proprietary portfolio of platform technologies can be multiplexed in specific products  that will target first the proteomics market and then clinical diagnostics with their unprecedented biomarker validation applications.

These products deriving from our proprietary platform technologies will target unmet needs by end-users and will therefore enable scientists to make measurements of biological molecules with greater accuracy and precision. These products will be first targeting the proteomics market and then the biomarker validation.